Biofarm will invest 47 million lei in upgrading equipment and developing a new R&D center by 2025.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
Biofarm, a leading Romanian drug manufacturer, plans to invest 47 million lei in upgrading its production plant on Logofătul Tăutu Street and developing a new research and development center. The project aims to modernize equipment in order to improve the efficiency of manufacturing processes and better respond to market demands. CEO Cătălin Vicol emphasizes that this initiative is part of Biofarm's strategy to increase its presence on international markets.
Sources
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare. Bugetul de investiţii al Biofarm în 2025 este de 47 mil. lei (aproape 10 mil. euro), în creştere faţă de anul anterior, cand a fost de 31 mil. lei
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare
Latest News
14:57
The remains of Tsar Samuel return to Bulgaria/ Athens hopes the gesture will support the request for the repatriation of the Parthenon Marbles
14:41
Disney will temporarily release the Ice Age films and the Percy Jackson series on Netflix to promote its upcoming productions
14:26
The owner of the Dristor Döner chain in Bucharest was arrested in Turkey as part of a large-scale investigation coordinated by the Ankara Prosecutor’s Office
14:13
Migrant trafficking network dismantled in Caraș-Severin/ Six DIICOT searches and dozens of people hidden in tractor-trailers bound for the West
14:02
Romania has the EU’s highest rate of housing overcrowding among young people
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
